Endoglin (CD105) as a novel serum marker for hepatocellular carcinoma in Egyptian patients with chronic liver disease
Authors:
- Mohga A. RedaMRMohga A. Reda
- Mohamed O. KhalifaMKMohamed O. Khalifa
- Yasser ElhosaryYEYasser Elhosary
- Dina KandilDKDina Kandil
- Ahmed EmaraAEAhmed Emara
- 1 July 2013
- journal article
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 3 (3) , 92-96
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancerBritish Journal of Cancer, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999